T

Toshinori Agatsuma

Daiichi Sankyo (Germany)

ORCID: 0000-0001-7319-9442

Publishes on HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Cancer therapeutics and mechanisms. 140 papers and 4.1k citations.

PubIndex Score96Top 4%How it's scored

140Publications

4.1kTotal Citations

First publication: 1989First senior author: 2012

HER2/EGFR in Cancer Research Monoclonal and Polyclonal Antibodies Research Cancer therapeutics and mechanisms Chemical Reactions and Isotopes HIV Research and Treatment

Top publicationsby citations

Bystander killing effect of <scp>DS</scp>‐8201a, a novel anti‐human epidermal growth factor receptor 2 antibody–drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneity

Yusuke Ogitani, Toshinori Agatsuma|Cancer Science|2016

Cited by 691

Raludotatug Deruxtecan, a CDH6-Targeting Antibody–Drug Conjugate with a DNA Topoisomerase I Inhibitor DXd, Is Efficacious in Human Ovarian and Kidney Cancer Models

Hirokazu Suzuki, Toshinori Agatsuma|Molecular Cancer Therapeutics|2024

Cited by 29

Novel Antibody Exerts Antitumor Effect through Downregulation of CD147 and Activation of Multiple Stress Signals

Keisuke Fukuchi, Toshinori Agatsuma|Journal of Oncology|2022

Cited by 7